Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Kura Oncology slammed the door on its takeover narrative Thursday, inking a deal for its leukemia drug. Kura stock crashed. The post Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26% appeared first on Investor's Business Daily.
Kura Oncology slammed the door on its takeover narrative Thursday, inking a deal for its leukemia drug. Kura stock crashed.
The post Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26% appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
